Kidney injury associated with COVID-19.
作者信息
Blum Daniel, Meraz-Munoz Alejandro, Harel Ziv
机构信息
Division of Nephrology (Blum), Jewish General Hospital, Montréal, Que.; Division of Nephrology (Meraz-Munoz, Harel) St. Michael's Hospital, Toronto, Ont.
出版信息
CMAJ. 2020 Sep 14;192(37):E1065. doi: 10.1503/cmaj.201553.
Abstract
摘要
相似文献
1
Kidney injury associated with COVID-19.与新型冠状病毒肺炎相关的肾损伤
CMAJ. 2020 Sep 14;192(37):E1065. doi: 10.1503/cmaj.201553.
2
The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic.冠状病毒感染中的肾素-血管紧张素-醛固酮系统——大流行期间的当前思考
J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1717-1719. doi: 10.1053/j.jvca.2020.04.010. Epub 2020 Apr 16.
3
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗？
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
4
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
5
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.在 COVID-19 大流行期间使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂：建模分析。
PLoS Comput Biol. 2020 Oct 8;16(10):e1008235. doi: 10.1371/journal.pcbi.1008235. eCollection 2020 Oct.
6
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.2019冠状病毒病（COVID-19）感染与肾素-血管紧张素系统阻滞剂
JAMA Cardiol. 2020 Jul 1;5(7):745-747. doi: 10.1001/jamacardio.2020.1282.
7
Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.内源性血管紧张素 II 中毒：COVID-19 假说。
Front Immunol. 2020 Jun 19;11:1472. doi: 10.3389/fimmu.2020.01472. eCollection 2020.
8
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.肾素-血管紧张素系统抑制剂对新型冠状病毒肺炎中2019冠状病毒感染及肺损伤的潜在差异影响
Hypertens Res. 2020 Aug;43(8):837-840. doi: 10.1038/s41440-020-0478-1. Epub 2020 May 20.
9
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
10
Acute Kidney Injury by SARS-CoV-2 virus in patients with COVID-19: an integrative review.新型冠状病毒肺炎患者中由严重急性呼吸综合征冠状病毒2引起的急性肾损伤：一项综合综述
Rev Bras Enferm. 2020;73 Suppl 2:e20200354. doi: 10.1590/0034-7167-2020-0354. Epub 2020 Jul 10.
引用本文的文献
1
Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury.新冠病毒感染合并肾损伤患者血栓形成的发病机制及早期抗凝治疗中的循环微颗粒
Front Cell Dev Biol. 2022 Jan 18;9:784505. doi: 10.3389/fcell.2021.784505. eCollection 2021.
2
[Not Available].[无可用内容]。
CMAJ. 2021 Jun 7;193(23):E859-E869. doi: 10.1503/cmaj.202795-f.
3
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area.多伦多地区因 COVID-19 和流感住院的特征和结果。
CMAJ. 2021 Mar 22;193(12):E410-E418. doi: 10.1503/cmaj.202795. Epub 2021 Feb 10.
本文引用的文献
1
Kidney Biopsy Findings in Patients with COVID-19.COVID-19 患者的肾脏活检结果。
J Am Soc Nephrol. 2020 Sep;31(9):1959-1968. doi: 10.1681/ASN.2020060802. Epub 2020 Jul 17.
2
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.中国武汉维持性血液透析患者 2019 年新型冠状病毒肺炎的临床特征。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1139-1145. doi: 10.2215/CJN.04160320. Epub 2020 May 22.
3
Acute kidney injury in patients hospitalized with COVID-19.COVID-19 住院患者中的急性肾损伤。
Kidney Int. 2020 Jul;98(1):209-218. doi: 10.1016/j.kint.2020.05.006. Epub 2020 May 16.
4
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
5
Kidney involvement in COVID-19 and rationale for extracorporeal therapies.COVID-19 相关的肾脏损害和体外治疗的原理。
Nat Rev Nephrol. 2020 Jun;16(6):308-310. doi: 10.1038/s41581-020-0284-7.
Zotero 插件